Related Experiment Video

Updated: Aug 20, 2026

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression

Hiroaki Suzuki1, Megumi Kurita, Kiyohisa Mizumoto

  • 1Department of Pharmacology, KEIO University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo160-8582, Japan.

Biochemical and Biophysical Research Communications
|November 30, 2004
PubMed

Insights

The ARF tumor suppressor targets BCL6, inhibiting its activity. This interaction, involving mouse p19(ARF) or human p14(ARF), contributes to ARF

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The ARF (Alternative Reading Frame) tumor suppressor gene plays a crucial role in preventing various cancers.
  • ARF-mediated tumor suppression can operate through both p53-dependent and p53-independent pathways.
  • BCL6 is a known transcriptional repressor implicated in various cellular processes and diseases.

Purpose of the Study:

  • To investigate the relationship between the ARF tumor suppressor and the BCL6 protein.
  • To determine if BCL6 is a direct target of ARF-mediated regulation.
  • To elucidate the mechanism by which ARF influences BCL6 activity.

Main Methods:

  • Co-immunoprecipitation assays to assess the binding of ARF to BCL6.
  • Reporter assays to measure BCL6-induced transcriptional repression.
  • Experiments using both mouse (p19ARF) and human (p14ARF) orthologs of ARF.

Main Results:

  • Demonstrated that both mouse p19(ARF) and human p14(ARF) directly bind to BCL6.
  • Showed that ARF binding leads to the downregulation of BCL6's transcriptional repression activity.
  • Established BCL6 as a novel target of the ARF tumor suppressor.

Conclusions:

  • ARF directly interacts with and inhibits the function of BCL6.
  • The downregulation of BCL6 activity by ARF is a significant mechanism contributing to ARF's tumor suppressive functions.
  • This finding provides new insights into the molecular pathways underlying ARF-mediated cancer prevention.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...